Graft-versus-leukemia effect following hematopoietic stem cell transplantation for leukemia

AM Dickinson, J Norden, S Li, I Hromadnikova… - Frontiers in …, 2017 - frontiersin.org
The success of hematopoietic stem cell transplantation (HSCT) lies with the ability of the
engrafting immune system to remove residual leukemia cells via a graft-versus-leukemia …

Long-term effects of pain in infants

FL Porter, RE Grunau, KJS Anand - Journal of Developmental & …, 1999 - journals.lww.com
Pain and stress have been shown to induce significant physiological and behavioral
reactions in newborn infants, even in those born prematurely. Infants who are born …

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party …

HJ Kolb, A Schattenberg, JM Goldman, B Hertenstein… - 1995 - ashpublications.org
The immune reactivity of allogeneic lymphocytes plays a major role in the control of
leukemia after bone marrow transplantation. In patients with recurrent leukemia after marrow …

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

C Bonini, G Ferrari, S Verzeletti, P Servida, E Zappone… - Science, 1997 - science.org
In allogeneic bone marrow transplantation (allo-BMT), donor lymphocytes play a central
therapeutic role in both graft-versus-leukemia (GvL) and immune reconstitution. However …

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

CM Rooney, CYC Ng, S Loftin, CA Smith, C Li… - The Lancet, 1995 - Elsevier
Summary Reactivation of Epstein-Barr virus (EBV) after bone-marrow transplantation leads
in many cases to lymphoproliferative disease that responds poorly to standard therapy and …

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia

JJ Molldrem, PP Lee, C Wang, K Felio, HM Kantarjian… - Nature medicine, 2000 - nature.com
Although the immune system has long been implicated in the control of cancer, evidence for
specific and efficacious immune responses in human cancer has been lacking. In the case …

Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of …

S Mackinnon, EB Papadopoulos, MH Carabasi… - 1995 - ashpublications.org
Infusions of large numbers (> 10 (8)/kg) of donor leukocytes can induce remissions in
patients with chronic myeloid leukemia (CML) who relapse after marrow transplantation. We …

[HTML][HTML] Graft-versus-myeloma effect: proof of principle

G Tricot, DH Vesole, S Jagannath, J Hilton, N Munshi… - Blood, 1996 - Elsevier
The presence of a graft-versus-tumor effect has been well established in leukemia but not in
multiple myeloma. A 40-year-old patient with myeloma refractory to standard chemotherapy …

Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in …

PD Kottaridis, RE Gale, SE Langabeer… - Blood, The Journal …, 2002 - ashpublications.org
FLT3 mutations, either internal tandem duplications (ITDs) or aspartate residue 835 (D835)
point mutations, are present in approximately one third of patients with acute myeloid …

[PDF][PDF] Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell …

P Bader, H Kreyenberg, W Hoelle… - Journal of clinical …, 2004 - researchgate.net
Purpose We recently reported that children with acute leukemias who show increasing
mixed chimerism (MC) after allogeneic stem-cell transplantation have a significantly …